Tivic Health Systems, Inc.

Equities

TIVC

US8887052095

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 01:30:00 11/05/2024 am IST			5-day change	1st Jan Change
0.5051 ^USD	-14.39%		-51.69%	-71.94%

08/05	Tivic Health Announces Successful Completion of Non-Invasive Vagus Nerve Stimulation Study; Demonstrates Clinically Effective Biological Changes in the Autonomic, Cardiac, and Central Nervous Systems	CI
25/03	Transcript : Tivic Health Systems, Inc., 2023 Earnings Call, Mar 25, 2024

Tivic Health Systems, Inc. Announces Termination of Ryan Sabia as Chief Operating Officer

January 27, 2024 at 03:00 am IST

Tivic Health Systems, Inc. announced on January 22, 2024, Ryan Sabia was terminated as an employee and chief operating officer of the company, effective immediately. As a result of his termination, his executive offer letter agreement dated April 1, 2022 also terminated on January 22, 2024.

Latest news about Tivic Health Systems, Inc.

Tivic Health Announces Successful Completion of Non-Invasive Vagus Nerve Stimulation Study; Demonstrates Clinically Effective Biological Changes in the Autonomic, Cardiac, and Central Nervous Systems	08/05	CI
Transcript : Tivic Health Systems, Inc., 2023 Earnings Call, Mar 25, 2024	26/03
Tivic Health Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03	CI
Tivic Health Announces Completion of Enrollment for Study of Novel Non-Invasive Bioelectronic Approach to Vagus Nerve Stimulation	21/02	CI
Tivic Health®? Systems, Inc. Enters Exclusive Distribution Agreement with Top 10 Medical Product Distributor for Mass Market Retail	30/01	CI
Tivic Health Systems, Inc. Announces Termination of Ryan Sabia as Chief Operating Officer	27/01	CI
Tivic Health Systems, Inc. Announces Launch of Second Generation of Tivic ClearUP	08/01	CI
Top Premarket Decliners	15/11	MT
Tivic Health Systems Seeks M&A	15/11	CI
Transcript : Tivic Health Systems, Inc., Q3 2023 Earnings Call, Nov 14, 2023	15/11
Earnings Flash (TIVC) TIVIC HEALTH SYSTEMS Posts Q3 Revenue $282,000	15/11	MT
Tivic Health Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
Top Premarket Gainers	13/11	MT
Tivic Health Partners with Instep Health to Access over 2,500 Healthcare Providers and Their Patients	26/23/26	CI
Tivic Health Systems Regains Compliance With Nasdaq's Minimum Bid Price Rule	20/23/20	MT
Top Premarket Gainers	29/23/29	MT
Tivic Health's Products to be Offered on AmerisourceBergen Marketplace	28/23/28	MT
Tivic Health Systems, Inc. Signs Agreement with AmerisourceBergen for Retail Pharmacy Customers	28/23/28	CI
Sector Update: Health Care Stocks Slipping Late Afternoon	23/23/23	MT
Sector Update: Health Care	23/23/23	MT
Tivic Health Systems Declares 1-for-100 Reverse Stock Split; Shares Fall	22/23/22	MT
Top Midday Gainers	16/23/16	MT
Tivic Health Funded Study Begins Enrollment for Novel Non-Invasive Bioelectronic Approach to Vagus Nerve Stimulation	16/23/16	CI
Earnings Flash (TIVC) TIVIC HEALTH SYSTEMS Reports Q2 Revenue $161,000, vs. Street Est of $0.63M	15/23/15	MT
Tivic Health Systems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI

Chart Tivic Health Systems, Inc.

Duration

Period

More charts

Company Profile

Tivic Health Systems, Inc. is a commercial-stage health tech company advancing the field of bioelectronic medicine. The Companyâs patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures. Its non-invasive and targeted approach to the treatment of inflammatory chronic health conditions is intended to give consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. The Companyâs first commercial product, ClearUP, is an FDA approved handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and available through online retailers and commercial distributors. ClearUP is sold in the U.S. directly to consumers on various platforms and through reseller channels. The Company is also focused on its intellectual property (IP) portfolio and research programs related to vagus nerve stimulation to expand its applications in non-invasive bioelectronic medicine.

Sector

Advanced Medical Equipment & Technology

Calendar

13/05/2024 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
TIVIC HEALTH SYSTEMS, INC.	-71.94%	741K
THERMO FISHER SCIENTIFIC	+11.73%	226B
DANAHER CORPORATION	+9.53%	188B
INTUITIVE SURGICAL, INC.	+14.63%	137B
BOSTON SCIENTIFIC CORPORATION	+27.47%	108B
SIEMENS HEALTHINEERS AG	-0.04%	63.19B
EDWARDS LIFESCIENCES CORPORATION	+13.73%	52.26B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.86%	51B
AGILENT TECHNOLOGIES, INC.	+7.72%	43.89B
GE HEALTHCARE TECHNOLOGIES INC.	+7.86%	38.07B

Other Advanced Medical Equipment & Technology